Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer

Radiotherapy and Oncology

Volumn 99, Issue 3, 2011, Pages 356-361

  Pratesi, Nicola ^a   Mangoni, Monica ^a   Mancini, Irene ^a   Paiar, Fabiola ^a   Simi, Lisa ^a   Livi, Lorenzo ^a   Cassani, Sara ^a   Buglione, Michela ^b   Grisanti, Salvatore ^c   Almici, Camillo ^c   Polli, Caterina ^d   Saieva, Calogero ^e   Magrini, Stefano Maria ^b   Biti, Giampaolo ^a   Pazzagli, Mario ^a   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Department of Medical Oncology ^*  (Italy)

^d Azienda USL N 4   (Italy)

^e Scientific Institute of Tuscany   (Italy)

Author keywords

Head and neck cancer; Radiotherapy; Single nucleotide polymorphisms; Toxicities

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; FLUOROURACIL; GLUTATHIONE TRANSFERASE P1; PLATINUM DERIVATIVE; RAD51 PROTEIN; TAXANE DERIVATIVE; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DYSPHAGIA; ERYTHEMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEAD AND NECK CARCINOMA; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; ALLELES; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HEAD AND NECK NEOPLASMS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RAD51 RECOMBINASE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 79960366539     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.062     Document Type: Article

References (39)

1. A. Jemal, T. Murray, and E. Ward Cancer statistics CA Cancer J Clin 55 2005 10 30
2. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis MACH-NC collaborative G Radiother Oncol 92 2009 4 14
3. S.M. Bentzen, and J. Overgaard Patient-to-patient variability in the expression of radiation-induced normal tissue injury Semin Radiat Oncol 4 1994 68 80 (Pubitemid 24116945)
4. O. Popanda, R. Ebbeler, and D. Twardella Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy Int J Radiat Oncol Biol Phys 55 2003 1216 1225 (Pubitemid 36338287)
5. C.N. Andreassen, and J. Alsner Genetic variants and normal tissue toxicity after radiotherapy: a systematic review Radiother Oncol 92 2009 299 309
6. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity-are we on the right track? Radiother Oncol 97 2010 1 8
7. K. Wiebalk, P. Schmezer, and S. Kropp In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy Int J Cancer 121 2007 2340 2345 (Pubitemid 47592098)
8. J. Chang-Claude, O. Popanda, and X.L. Tan Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients Clin Cancer Res 11 2005 4802 4809 (Pubitemid 41557201)
9. Mangoni M, Bisanzi S, Carozzi F, et al. Association between Genetic Polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT Genes and Radiosensitivity in Breast Cancer Patients. Int J Radiat Oncol Biol Phys 2010; doi:10.106/j.ijrobp.2010.04.023.
10. D. Azria, Y. Belkacemi, and J.L. Lagrange Radiation-induced sequelae: toward an individual profile Cancer Radiother 12 2008 619 624
11. J. Alsner, C.N. Andreassen, and J. Overgaard Genetic markers for prediction of normal tissue toxicity after radiotherapy Semin Radiat Oncol 18 2008 126 135 (Pubitemid 351296451)
12. O. Popanda, J.U. Marquardt, J. Chang-Claude, and P. Schmezer Genetic variation in normal tissue toxicity induced by ionizing radiation Mutat Res 667 2009 58 69
13. L.A. Henríquez Hernández, P.C. Lara, and B. Pinar Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy Radiat Oncol 4 2009 17
14. D. Azria, M. Ozsahin, and A. Kramar Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy Clin Cancer Res 14 2008 6284 6288
15. J. Carles, M. Monzo, and M. Amat Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer Int J Radiat Oncol Biol Phys 66 2006 1022 1030 (Pubitemid 44633517)
16. J. Werbrouck, K. De Ruyck, and F. Duprez Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes Int J Radiat Oncol Biol Phys 73 2009 1187 1195
17. M. Christmann, M.T. Tomicic, W.P. Roos, and B. Kaina Mechanisms of human DNA repair: an update Toxicology 193 2003 3 34 (Pubitemid 37340141)
18. A.E. Vidal, S. Boiteux, I.D. Hickson, and J.P. Radicella XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions EMBO J 20 2001 6530 6539 (Pubitemid 33078725)
19. L.H. Thompson, and M.G. West XRCC1 keeps DNA from getting stranded Mutat Res 459 2000 1 18 (Pubitemid 30085463)
20. T. Langsenlehner, W. Renner, and A. Gerger Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients Radiother Oncol 98 2011 387 393
21. O. Zschenker, A. Raabe, and I.K. Boeckelmann Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity Radiother Oncol 97 2010 26 32
22. M.Z. Zdzienicka, G.P. van der Schans, and A.T. Natarajan A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges Mutagenesis 7 1992 265 269
23. Y. Wang, M.R. Spitz, and Y. Zhu From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity DNA Repair (Amst) 2 2003 901 908 (Pubitemid 37297454)
24. C. Wiese, D.W. Collins, and J.S. Albala Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells Nucleic Acids Res 30 2002 1001 1008 (Pubitemid 34679669)
25. M.H. Bourguignon, P.A. Gisone, and M.R. Perez Genetic and epigenetic features in radiation sensitivity Part II: implications for clinical practice and radiation protection Eur J Nucl Med Mol Imaging 32 2005 351 368 (Pubitemid 40562128)
26. J. Sun, Y. Chen, M. Li, and Z. Ge Role of antioxidant enzymes on ionizing radiation resistance Free Radic Biol Med 24 1998 586 593 (Pubitemid 28150477)
27. S.A. Geisler, A.F. Olshan, and J. Cai Glutathione S-transferase polymorphisms and survival from head and neck cancer Head Neck 27 2005 232 242 (Pubitemid 40315772)
28. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 (http://ctep.cancer.gov), Publish Date: August 9, 2006.
29. J.F. Fowler Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer Int J Radiat Oncol Biol Phys 21 1991 1451 1456
30. D. Collett Modelling survival data in medical research 2003 Chapman & Hall/CRC Boca Raton FL, USA
31. O. Popanda, X.L. Tan, and C.B. Ambrosone Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients Cancer Epidemiol Biomarkers Prev 15 2006 1048 1050 (Pubitemid 43823540)
32. Z. Mo, Y. Gao, and Y. Cao An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review Prostate 69 2009 662 688
33. E.J. Duell, J.K. Wiencke, and T.J. Cheng Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells Carcinogenesis 21 2000 965 971 (Pubitemid 30265141)
34. S.Z. Abdel-Rahman, and R.A. El-Zein The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK Cancer Lett 159 2000 63 71
35. K.K. Divine, F.D. Gilliland, and R.E. Crowell The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung Mutat Res 461 2001 273 278
36. L. Kadouri, Z. Kote-Jarai, and A. Hubert A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers Br J Cancer 90 2004 2002 2005 (Pubitemid 38746344)
37. S. Costa, D. Pinto, and D. Pereira DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population Breast Cancer Res Treat 103 2007 209 217 (Pubitemid 46789140)
38. A.C. Antoniou, O.M. Sinilnikova, and J. Simard Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). RAD51 135G - >C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies Am J Hum Genet 81 2007 1186 1200 (Pubitemid 350211449)
39. Z.H. Huang, D. Hua, and X. Du Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy Cancer Chemother Pharmacol 64 2009 1001 1007